Kevin Heal

Stock Analyst at Argus Research

(3.21)
# 1,000
Out of 4,759 analysts
46
Total ratings
64.52%
Success rate
8.6%
Average return

Stocks Rated by Kevin Heal

Nasdaq
Nov 5, 2024
Maintains: Buy
Price Target: $76$82
Current: $74.66
Upside: +9.83%
Regions Financial
Oct 24, 2024
Upgrades: Buy
Price Target: $26
Current: $22.07
Upside: +17.81%
Zions Bancorporation, National Association
Jul 25, 2024
Downgrades: Hold
Price Target: n/a
Current: $50.15
Upside: -
Huntington Bancshares
Jul 22, 2024
Maintains: Buy
Price Target: $15$16
Current: $15.14
Upside: +5.68%
MetLife
May 22, 2024
Maintains: Buy
Price Target: $77$80
Current: $82.25
Upside: -2.74%
Intercontinental Exchange
May 21, 2024
Reiterates: Buy
Price Target: $153
Current: $170.24
Upside: -10.13%
Ameriprise Financial
May 6, 2024
Maintains: Buy
Price Target: $440$460
Current: $499.34
Upside: -7.88%
Citizens Financial Group
Apr 24, 2024
Maintains: Buy
Price Target: $36$39
Current: $41.64
Upside: -6.34%
CME Group
Mar 6, 2024
Maintains: Buy
Price Target: $225$245
Current: $254.57
Upside: -3.76%
Rithm Capital
Mar 5, 2024
Maintains: Buy
Price Target: $11$12
Current: $11.82
Upside: +1.52%
Downgrades: Hold
Price Target: n/a
Current: $58.30
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $213.00
Upside: -
Upgrades: Hold
Price Target: n/a
Current: $15.77
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $21.85
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $10.38
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $6.39
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $200.73
Upside: -
Upgrades: Buy
Price Target: $185
Current: $286.59
Upside: -35.45%